GRI Bio, Inc News, GRI Bio, Inc Quote, GRI Quote

GRI Bio, Inc (NQ:GRI) Delayed: 1.50 -0.04 (2.6%)

Prev. Close

$1.54

Today 6M 1Y 5Y

Open

$1.54

52 Wk High

$47.03

52 Wk Low

$37.79

Day High

$1.55

Day Low

$1.47

P/E

N/A

EPS

$0.00

Volume

47,558

Friends, Peers and Foes (?): AKTX, AMIX, CNSP, MBRX, NUWE (more...)

ALERTS | RSS

Jun 18, 2026 04:51 PM Form 8-K GRI Bio, Inc. For: Jun 18
Jun 18, 2026 08:32 AM FDA grants orphan drug status to GRI Bio's GRI-0621 for lung disease
Jun 18, 2026 08:31 AM GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
May 18, 2026 09:15 AM GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
May 14, 2026 08:36 AM Form 8-K GRI Bio, Inc. For: May 14
May 14, 2026 08:35 AM GRI Bio reports Q1 2026 results, advances drug pipeline
May 14, 2026 08:35 AM GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Im
May 13, 2026 04:42 PM Form SCHEDULE 13G/A GRI Bio, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
May 13, 2026 04:17 PM Form 10-Q GRI Bio, Inc. For: Mar 31
Apr 8, 2026 08:30 AM GRI Bio receives UAE patent allowance for NKT cell agonists

Entities mentioned with GRI

View All Entities